Jay B. Bartels

CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA.

CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA.

The Germinator, Inc. (The Germinator) is a venture capital firm founded in 2005. The firm is headquartered in Menlo Park, California.

Webify Solutions, Inc. provided enterprise software and other computer related services. It focused on the healthcare, insurance, banking and telecom markets. The company was founded in 2002 and was located in Austin, TX

CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA.